Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study (Q45227732)
Jump to navigation
Jump to search
scientific article published on 17 January 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study |
scientific article published on 17 January 2005 |
Statements
1 reference
Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study (English)
1 reference
1 reference
Muhammad Q S Mir
1 reference
Faiz A Cheema
1 reference
Nadya Khan-Merchant
1 reference
Rekha G Menon
1 reference
Sampath Parthasarathy
1 reference
Bobby V Khan
1 reference
17 January 2005
1 reference
1 reference
Identifiers
1 reference